ENZYVANT THERAPEUTICS GMBH

Lobbying Spend

—

Filings

Firms Hired

Active Period

2018–2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	1	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
JEFFREY J. KIMBELL & ASSOCIATES, INC.	—	25

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	22
SENATE	22
Centers For Medicare and Medicaid Services (CMS)	5
Food & Drug Administration (FDA)	4
Health & Human Services, Dept of (HHS)	3
Office of Management & Budget (OMB)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	23
Medicare/Medicaid	Medicare/Medicaid	1

ENZYVANT THERAPEUTICS GMBH — Lobbying Disclosure | Poliscope